Skip To Main Content
Henry C. Barry on Muck Rack

Henry C. Barry

As seen in: MDEdge, Annals of Family Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Henry C.

Contact Henry C., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Should Metformin Continue as First-Line Pharmacotherapy for Patients With Type 2 Diabetes? No: Other Drugs Have Stronger Evidence of Benefit

|
By Henry C. Barry
| aafp.org
Am Fam Physician. 2024;109(3):202-203 Related Editorial: Should Metformin Continue as First-Line Pharmacotherapy for Patients With Type 2 Diabetes? Yes: Metformin Is Still the Best Choice This is one in a series of pro/con editorials discussing controversial issues in family medicine. Author disclosure: No relevant financial relationships.
Open in Who Shared Issue with article?

Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis

|
By Mark H. Ebell, Henry C. Barry, Kanishka Baduni, Gabrielle M. Grasso Verified
| Annals of Family Medicine Verified
Abstract PURPOSE We conducted a meta-analysis to evaluate clinically meaningful benefits and harms of monoclonal antibodies targeting amyloid in patients with Alzheimer dementia. METHODS We searched PubMed, Cochrane CENTRAL, and 5 trial registries, as well as the reference lists of identified studies. We included randomized controlled trials comparing a monoclonal antibody with placebo at a dose consistent with that used in phase 3 trials or for Food and Drug Administration approval.
Open in Who Shared Issue with article?

Morning and Bedtime Dosing of Antihypertensives Have Similar Rates of Major Cardiovascular Events

|
By Henry C. Barry
| ncbi.nlm.nih.gov
Would you like email updates of new search results? Send even when there aren't any new results
Open in Who Shared View Duplicates (52) Issue with article?
See all 26 articles